Key facts
- This page summarizes Stuart Essig's Form 4 filing for INTEGRA LIFESCIENCES HOLDINGS CORP (IART).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 May 2023, 16:11.
Stuart Essig - 12 May 2023 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
- Reporting relationship
- Director
- Issuer ticker
- IART
- Reported as of
- 12 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 May 2023, 16:11:21 UTC
- Prior SEC filing
- 15 May 2023
- Next SEC filing
- 19 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Schwartz; Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stuart Essig filed Form 4 for INTEGRA LIFESCIENCES HOLDINGS CORP (IART) on 16 May 2023.
Change
- Previous filing in this sequence was filed on 15 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IART
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,505
- Change %
- +0.48%
- Price
- $0.000000
- Shares after
- 1,152,329
- Date
- 12 May 2023
- Ownership
- Direct
IART
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 534,629
- Date
- 12 May 2023
- Ownership
- By Trust
* marks a reported price that did not pass the local price check.